Clinical Trial Update: B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes

View source ↗

Summary

A completed retrospective study assessing treatment practices and outcomes in classical Hodgkin lymphoma, including relapsed or refractory cases, sponsored by T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma
• Or Refractory Classical Hodgkin Lymphoma

Snippet

Sponsor: Takeda | Conditions: Classical Hodgkin Lymphoma, Relapsed or Refractory Classical Hodgkin Lymphoma | Status: COMPLETED | Results posted: 2021-06-25